Truist Financial Corp Sells 59,791 Shares of Haleon plc (NYSE:HLN)

Truist Financial Corp reduced its position in shares of Haleon plc (NYSE:HLN) by 7.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 753,036 shares of the company’s stock after selling 59,791 shares during the quarter. Truist Financial Corp’s holdings in Haleon were worth $6,197,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in HLN. FMR LLC raised its position in shares of Haleon by 22.2% during the third quarter. FMR LLC now owns 53,951,936 shares of the company’s stock worth $449,420,000 after purchasing an additional 9,812,040 shares during the period. Wellington Management Group LLP bought a new position in shares of Haleon in the third quarter valued at $42,640,000. Envestnet Asset Management Inc. lifted its stake in shares of Haleon by 121.2% in the third quarter. Envestnet Asset Management Inc. now owns 5,931,187 shares of the company’s stock valued at $49,407,000 after buying an additional 3,249,517 shares in the last quarter. Cambiar Investors LLC acquired a new position in shares of Haleon during the fourth quarter valued at about $15,225,000. Finally, Kayne Anderson Rudnick Investment Management LLC increased its position in shares of Haleon by 6,593.0% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,692,937 shares of the company’s stock worth $14,102,000 after acquiring an additional 1,667,643 shares in the last quarter. Institutional investors own 6.67% of the company’s stock.

Haleon Trading Down 0.2 %

NYSE:HLN opened at $8.30 on Friday. Haleon plc has a 52 week low of $7.70 and a 52 week high of $8.98. The firm has a 50-day moving average price of $8.33 and a two-hundred day moving average price of $8.29. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.73 and a current ratio of 1.04. The firm has a market cap of $37.90 billion, a price-to-earnings ratio of 27.67, a price-to-earnings-growth ratio of 2.18 and a beta of 0.28.

Haleon Dividend Announcement

The firm also recently declared a semi-annual dividend, which will be paid on Thursday, May 16th. Investors of record on Friday, March 15th will be issued a dividend of $0.1064 per share. The ex-dividend date of this dividend is Thursday, March 14th. This represents a yield of 1.8%. Haleon’s dividend payout ratio (DPR) is currently 70.00%.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Argus reiterated a “buy” rating on shares of Haleon in a research note on Tuesday, March 26th. HSBC assumed coverage on Haleon in a report on Wednesday, April 17th. They set a “buy” rating for the company. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy”.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.